OxStem
OxStem is a small molecule discovery company targeting innate regeneration and repair.
OxStem was founded by three eminent Oxford University professors with the goal of using small molecules to activate or re-program tissue-resident (endogenous) stem and progenitor cells. The founders were joined by thirteen world-leading Oxford scientists and physicians with respective expertise in OxStem's five programs: haematological malignancies, neurodegenerative diseases, retinal diseases, cardiovascular disease and diabetes.
